CMPX R&D Expenses
Compass Therapeutics · R&D Expenses
CMPX R&D Expenses
Latest reported$19.58Mperiod ending
CMPX Quarterly R&D Expenses ($0.00 → $19.58M)
Quarterly R&D Expenses
High-resolution chart · PNG
CMPX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 19,576,000 | |
| 13,375,000 | |
| 13,674,000 | |
| 12,826,000 | |
| 16,415,000 | |
| 13,054,000 | |
| 13,038,000 | |
| 8,612,000 | |
| 11,174,000 | |
| 9,522,000 | |
| 12,426,000 | |
| 8,831,000 | |
| 10,223,000 | |
| 6,638,000 | |
| 9,928,000 | |
| 9,791,000 | |
| 5,862,000 | |
| 4,415,000 | |
| 9,574,000 | |
| 3,154,000 | |
| 2,905,000 | |
| 4,704,000 | |
| 4,406,000 | |
| 3,670,000 | |
| 2,985,000 | |
| 3,571,000 | |
| 3,303,000 | |
| 5,979,000 | |
| 5,389,000 | |
| 7,243,000 | |
| 0 |